Русский
Search Articles by Keyword
Found: 5 articles
| Article | Edition |
|---|---|
|
I.S. Gulian, E.P. Bystritskaya, N.Yu. Otstavnykh, E.V. Khudchenko, E.V. Eliseeva, V.I. Apanasevich, M.P. Isaeva
GSTT1 and GSTM1 deletion polymorphism as a predictor of response to hormonal therapy for breast cancer
|
№11 / 2023 |
|
E.O. Golubenko, M.I. Savelyeva, I.V. Poddubnaya, V.V. Korennaya
Possibilities of a pharmacogenetic approach to solving gynecological problems in patients taking tamoxifen: a literature review
|
№11 / 2023 |
|
E.O. Golubenko, M.I. Savelyeva, Zh.A. Sozaeva, I.V. Poddubnaya, V.V. Korennaya
Clinical significance of genetic polymorphism of tamoxifen metabolic enzymes and transporters in breast cancer: results of a population-based cohort study
|
№11-12 / 2022 |
|
T.Yu. Semiglazova (1, 2), I.V. Berlev (1, 2), E.A. Ulrikh (1, 3), V.V. Semiglazov (1, 3), A.E. Protasova (2, 4), N.A. Brish (1), E.A. Korobeynikova (1), Yu.V. Alekseeva (1), L.V. Filatova (1, 2), A.I. Semenova (1), D.Kh. Latipova (1), G.M. Teletaeva (1), E.V. Tkachenko (1), V.V. Klimenko (1), G.A. Dashyan (1), S.A. Protsenko (1), R.M. Paltuev (1), A.F. Urmancheeva (1, 2), P.V. Krivorotko (1, 2), V.F. Semiglazov (1, 2)
GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
|
№7 / 2018 |
|
A.A. Moiseyev
ROLE OF PHARMACOGENETICS IN INDIVIDUALIZING OF ANTICANCER CHEMOTHERAPY
|
№8 / 2013 |
